Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoGen Inc (NASDAQ:IMGN)

4.31
Delayed Data
As of 12:24pm ET
 -0.045 / -1.03%
Today’s Change
1.51
Today|||52-Week Range
8.79
+111.03%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Revenue and IncomeNet Revenues19.7M7.4M7.7M13.8M
 
 
 
 
 
Depreciation And Amortization1.4M1.5M1.5M--
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses45.9M45.3M40.8M42.2M
 
 
 
 
 
Research And Development36.1M37.5M32.9M33.7M
 
 
 
 
 
Total Operating Expenses47.3M46.8M42.4M42.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-27.6M-39.4M-34.7M-28.3M
 
 
 
 
 
Extraordinary Charge0.000.00-4.1M-301.0K
 
 
 
Interest Expense On Debt5.0M--6.2M4.7M
 
 
 
 
Other Expenses551.0K-5.4M129.0K-758.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-31.9M-44.8M-44.7M-34.2M
 
 
 
 
 
Net Income-31.9M-44.8M-44.7M-34.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS87.0M87.1M87.1M--
 
 
 
 
Shares To Calculate EPS Diluted87.0M87.1M87.1M87.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.37-$0.51-$0.51-$0.39
 
 
 
 
 
EPS Diluted-$0.37-$0.51-$0.51-$0.39